Afynia Laboratories, a Canadian biotech startup spun out from McMaster University, has secured $5 million in seed funding to commercialize its blood test for endometriosis. The round was led by Bio-Rad Laboratories, with participation from Impact America Fund, SOSV, the Capital Angel Network, and Gaingels.
Read original article.